Ackeifi, Courtney <br/><br/>
GLP-1 receptor agonists synergize with DYRK1A inhibitors to potentiate functional human β cell regeneration.  [electronic resource] 

 -  Science translational medicine  02 2020 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1946-6242 
<br/><br/><label>Standard No.: </label>10.1126/scitranslmed.aaw9996  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Animals<br/>Diabetes Mellitus, Type 2<br/>Humans<br/>Insulin-Secreting Cells<br/>Mice<br/>Protein Kinase Inhibitors--pharmacology<br/>Protein Serine-Threonine Kinases--antagonists & inhibitors<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Regeneration<br/>Dyrk Kinases<br/>Glucagon-Like Peptide-1 Receptor Agonists